NorthWest Biotherapeutics Inc (NWBO)

[Nick119]

You didn't ask me, but there are many ground-breaking outcomes as part of this phase 3 trial's conclusion most notably:

-A change in how oncology trials are conducted in the future through the elimination of an unethical placebo group by use of historical controls.

-A disruption in the standard of care, initially for GBM, but setting a baseline for further disruption soon after for all solid tumor cancers.

These are the reasons for a peer-reviewed publication in a MAJOR, TOP-TIER (their words, not mine) medical journal.

The burden of ensuring all t's are crossed and i's are dotted in today's new covid world order (as exwannabe puts it) are a significant part of the reasons for the delay.

The end result will be alignment across all regulatory parties, the medical community, and patient advocacy groups for the perfect, irrefutable, ground-breaking treatment to change the outcomes of cancer patients world-wide.